SCHEMBL5008293

SCHEMBL5008293

COC(=O)c1ccc(C(OC)C(N)=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.56
ALDH1A1 P00352 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
CA1 P00915 4/20 0.50
CA2 P00918 4/20 0.50
MAPT P10636 4/20 0.50
CA12 O43570 3/20 0.50
CA9 Q16790 3/20 0.50
CA14 Q9ULX7 3/20 0.50
TDP1 Q9NUW8 1/20 0.50
CA7 P43166 1/20 0.50
LOXL2 Q9Y4K0 1/20 0.49
RAB9A P51151 2/20 0.48
KMT2A Q03164 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TSHR P16473 1/20 0.47
STS P08842 1/20 0.45
DPP4 P27487 2/20 0.44
NPC1 O15118 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5009753 0.84 KMT2A (0.49) GAAALDH1A1L3MBTL1CA1CA2
SCHEMBL7888656 0.84 GAA (0.62) GAAALDH1A1L3MBTL1CA1CA2
SCHEMBL7473286 0.80 MAPT (0.56) GAAALDH1A1CA1CA2MAPT
SCHEMBL8252070 0.80 CA1 (0.52) GAAALDH1A1CA1CA2MAPT
SCHEMBL4280687 0.79 ESR1 (0.42) CA1CA2MAPTCA12CA9
SCHEMBL14487971 0.79 CA1 (0.50) GAAALDH1A1CA1CA2MAPT
Urea SCHEMBL20838278 0.78 CA1 (0.70) GAAALDH1A1L3MBTL1CA1CA2
SCHEMBL19734679 0.78 AOC3 (0.42) GAAALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL29920956 0.78 ALOX5 (0.47) ALDH1A1L3MBTL1MAPTRAB9AKMT2A
SCHEMBL29921041 0.78 KMT2A (0.45) ALDH1A1L3MBTL1KMT2ASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1884513-A1 PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME Japan Tobacco, Inc. (JP) 2008-02-06 EP claimed
US-20070032529-A1 Pyrazole compounds and their use as antidiabetes agents JAPAN TOBACCO INC. (JP) 2007-02-08 US claimed
EP-1884513-A1 PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME Japan Tobacco, Inc. (JP) 2008-02-06 EP disclosed
US-20070032529-A1 Pyrazole compounds and their use as antidiabetes agents JAPAN TOBACCO INC. (JP) 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032529-A1 Pyrazole compounds and their use as antidiabetes agents PYGL, GYS2, AGL GAA 53/4885ALDH1A1 1278/4885L3MBTL1 2102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.